Loading clinical trials...
Loading clinical trials...
In the current study, we will examine how two types of concentration meditation practices affect plasma biomarkers of Alzheimer's Disease (AD). We will also examine the effects of the two types of meditation practices on emotional well-being and episodic memory. Healthy adults aged 18-35 who meet all eligibility criteria will be invited to this study. Participants will be asked to engage in one week of daily meditation practice or no-intervention control task at home. They will also be asked to visit the lab twice, once before and once after the intervention, to provide blood samples to assess plasma biomarkers of AD and to complete emotion questionnaires and a memory test.
Age
18 - 35 years
Sex
ALL
Healthy Volunteers
Yes
University of Southern California
Los Angeles, California, United States
Start Date
January 29, 2024
Primary Completion Date
May 3, 2024
Completion Date
May 3, 2024
Last Updated
January 5, 2026
94
ACTUAL participants
Belly-focus meditation
BEHAVIORAL
Belly-focus meditation with slow breathing
BEHAVIORAL
Lead Sponsor
University of Southern California
Collaborators
NCT04123314
NCT07178210
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions